Portal cavernoma in type 1 neurofibromatosis: A fortuitous or causal association?
American Journal of Medical Genetics Part A · 2023
DOI: 10.1002/ajmg.a.63219 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2023. Verfasst von Joanna Ashworth und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics Division, Child and Adolescent Department, Centro Materno Infantil do Norte, Centro Hospitalar Universitário de Santo António, Porto, Port…. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Hypertension, Portal, Venous Thrombosis, Vascular Diseases. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Neurofibromatosis type 1 (NF‐1) is a multisystem genetic disorder affecting the NF1 tumor suppressor gene. Patients typically develop superficial (cutaneous) and internal (plexiform) neurofibromas. The latter may rarely involve the liver locating in the hilum and encasing the portal vessels, leading to portal hypertension. Vascular abnormalities ( NF‐I vasculopathy ) are a well‐recognized manifestation of NF‐1. Although the pathogenesis is not well‐known, NF‐1 vasculopathy involves arteries of both peripheral and cerebral territories, with venous thrombosis being exceptionally reported. Portal venous thrombosis (PVT) is the leading cause of portal hypertension in childhood and has been associated with several risk factors. Nevertheless, predisposing conditions remain unknown in more than 50% of the cases. The treatment options are limited, and its management is nonconsensual in the pediatric age. We report the case of a 9‐year‐old boy with clinically and genetically confirmed NF‐1, diagnosed with portal venous cavernoma after an episode of gastrointestinal bleeding. There were no identifiable risk factors for PVT and intrahepatic peri‐hilar plexiform neurofibroma was excluded by MRI imaging. To the best of our knowledge, this is the first report of PVT in NF‐1. We speculate that NF‐1 vasculopathy may have been a pathogenic factor, or instead, it was a fortuitous association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatrics Division, Child and Adolescent Department, Centro Materno Infantil do Norte, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
- Neuroradiology Department, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
- Paediatric Haematology Unit, Pediatrics Division, Child and Adolescent Department, Centro Materno Infantil do Norte, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
- Gastroenterology Unit, Pediatrics Division, Hospital Pediátrico de Coimbra, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.
- Division of Pediatric Surgery, Hospital Pediátrico de Coimbra, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.
- Gastroenterology Unit, Pediatrics Division, Child and Adolescent Department, Centro Materno Infantil do Norte, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
ORCID-Profile: Joanna Ashworth
Zitieren
APA
Ashworth, J., Sousa Abreu, V., Couto Guerra, I., Almeida, S., Cunha, C., Moreira Silva, H., & Santos Silva, E. (2023). Portal cavernoma in type 1 neurofibromatosis: A fortuitous or causal association?. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63219
Vancouver
Ashworth J, Sousa Abreu V, Couto Guerra I, Almeida S, Cunha C, Moreira Silva H, et al. Portal cavernoma in type 1 neurofibromatosis: A fortuitous or causal association?. American Journal of Medical Genetics Part A. 2023. doi:10.1002/ajmg.a.63219
BibTeX
@article{Ashworth2023,
author = {Ashworth, Joanna and Sousa Abreu, Vasco and Couto Guerra, Isabel and Almeida, Susana and Cunha, Catarina and Moreira Silva, Helena and Santos Silva, Ermelinda},
title = {Portal cavernoma in type 1 neurofibromatosis: A fortuitous or causal association?},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
doi = {10.1002/ajmg.a.63219}
}
EUVIMED